Search for Clinical Trial Results
Pharyngeal Neoplasms - 100 Studies Found
Status | Study |
Recruiting |
Study Name: Integrated Cancer Repository for Cancer Research Condition:
|
Recruiting |
Study Name: 18F FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy Condition:
|
Recruiting |
Study Name: Transoral Robotic Surgery in Treating Patients With Benign or Malignant Tumors of the Head and Neck Condition:
|
Active, not recruiting |
Study Name: Phase 1b Food Based Modulation of Biomarkers in Human Tissues at High-Risk for Oral Cancer. Condition:
|
Withdrawn |
Study Name: Concordance of Two Endoscopic Procedures for Diagnosis of Carcinoma of the Upper Aerodigestive Tract Condition:
Interventions: |
Completed |
Study Name: Study of Alimta in Patients With Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Who Have Had Prior Platinum Based Chemotherapy Condition: Nasopharyngeal Neoplasms Date: 2008-02-25 Interventions: Drug: Pemetrexed (Alimta) 500 mg/m2 in Cycle 1, every 3 weeks, with folic acid and vitamin B12 supplemen |
Completed |
Study Name: Study of Combination of Sorafenib With Cisplatin and 5-fluorouracil as First-line Treatment of Recurrence After Radiotherapy Patients Who Failed With Radiotherapy in Recurrent or Metastatic Nasopharyngeal Carcinoma (NPC) Condition: Nasopharyngeal Neoplasms Date: 2008-09-04 Interventions: Drug: Sorafenib plus Cisplatin and 5-fluorouracil Sorafeni |
Not yet recruiting |
Study Name: Measuring Patient-Reported Adverse Events in Oncology Practice Improves Quality of Life in Nasopharyngeal Carcinoma Condition: Nasopharyngeal Neoplasms Date: 2017-03-16 Interventions:
|
Recruiting |
Study Name: A Trial of Endostar in Patients With Carcinoma of the Head and Neck Condition: Nasopharyngeal Neoplasms Date: 2016-08-12 Interventions: Drug: Endostar The patients will be randomized to CRT arm and CRT+Endostar arm. All patients will receiv |
Recruiting |
Study Name: Study of Pembrolizumab (MK-3475) in Platinum Pre-treated Recurrent/Metastatic Nasopharyngeal Cancer (MK-3475-122, KEYNOTE-122) Condition: Date: 2024-05-19 |